Integer Holdings Corp. ITGR 深 滬
已收盤 01-02 16:00:00 美东时间
76.78
-1.650
-2.10%
華盛通- 最 高78.375
- 今 開78.37
- 成交量 40.27万股
- 最 低 76.53
- 昨 收 78.43
- 總市值 26.90亿
- 52周最高 146.36
- 市盈率 靜 22.67
- 換手率 1.15%
- 52周最低 62.00
- 委 比 -33.33%
- 總股本 3503.84万
- 歷史最高 146.36
- 量 比 1.23
- 振 幅 2.35%
- 歷史最低 15.2167
- 每 手 1
- 風險率 21.29%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元
2025-12-19 10:15
'Activist Irenic Pushing Medical-Device Maker Integer to Pursue Sale'- WSJ
https://www.wsj.com/business/deals/activist-irenic-pushing-medical-device-maker-integer-to-pursue-sale-0a1b3fd4
2025-12-18 06:10
美股大行评级 | 绩后分化！甲骨文遭14家大行集体下调目标价；新思科技、Planet获多家机构上调目标价！
今日重点评级关注：HC Wainwright & Co.：维持Moleculin Biotech"买入"评级，目标价从4美元升至22美元；HC Wainwright & Co.：上调Soluna Holdings评级至"买入"，目标价5美元
2025-12-12 10:24
Citigroup Maintains Neutral on Integer Holdings, Raises Price Target to $75
Citigroup analyst Joanne Wuensch maintains Integer Holdings (NYSE:ITGR) with a Neutral and raises the price target from $69 to $75.
2025-12-12 05:03
美股大行评级 | 摩根大通上调百度至"超配"，目标价升至188美元！Navan获多家机构首予"买入"评级，目标价最高30美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从4美元升至9美元；BTIG：维持Cullinan Therapeutics"买入"评级，目标价从32美元升至38美元
2025-11-25 10:27
Truist Securities Maintains Buy on Integer Holdings, Lowers Price Target to $86
Truist Securities analyst Richard Newitter maintains Integer Holdings (NYSE:ITGR) with a Buy and lowers the price target from $88 to $86.
2025-11-25 02:12
Integer to Participate at Upcoming Investor Conferences
Integer Holdings Corporation announced that its executive leadership team will participate in two investor conferences in December: the Piper Sandler 37th Annual Healthcare Conference on Dec. 2 and Citi’s 2025 Global Healthcare Conference on Dec. 3. Links to live webcasts and replays are available on investor.integer.net. Integer is a leading medical device contract development and manufacturing organization. Learn more at www.integer.net.
2025-11-18 13:00
Integer Holdings Corporation Board Authorizes $200 Million Share Repurchase Program
Texas-based Integer Holdings announced a $200 million stock buyback program, reflecting confidence in its strategy and strong free cash flow generation. The company plans to use existing cash and free cash flows for the program, with management determining the timing and volume opportunistically. Integer, a leading medical device CDMO, serves markets including cardiac rhythm management and neuromodulation.
2025-11-04 13:00
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
2025-11-04 10:31
Citigroup Maintains Neutral on Integer Holdings, Lowers Price Target to $69
Citigroup analyst Joanne Wuensch maintains Integer Holdings (NYSE:ITGR) with a Neutral and lowers the price target from $77 to $69.
2025-11-04 04:15
